StratDeck

Two stocks in Healthcare

AbbVie vs Abbott Laboratories: profit, growth, debt and price compared

AbbVie is stronger on 3 of 6 figures: profit margin, dividend and price trend. Abbott Laboratories is stronger on 1: sales growth.

Figures as of 18 November 2026SEC EDGARYahoo Finance
Explore AbbVie's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

AbbVie and Abbott Laboratories side by side
AbbVieABBVAbbott LaboratoriesABT
Net marginStronger: 15.7%9.8%
Revenue growth, past year+10.32%Stronger: +14.46%
Debt to equity—60.9%
Forward P/E17.6×17.6×
Dividend yieldStronger: 2.42%2.41%
AnalystsBuy · 26Buy · 26
From its 200-day averageStronger: +15.5%0.0%

Share price over the past year

  • AbbVie+22.3%
  • Abbott Laboratories−19.6%

18 Nov 202518 Nov 2026

AbbVie or Abbott Laboratories: which is stronger?

  • ABBV

    Which is more profitable?

    AbbVie keeps more of each sale as profit: 15.7% against 9.8%.

  • ABT

    Which is growing its sales faster?

    Abbott Laboratories is growing its sales faster: +14.46% over the past year, against +10.32%.

  • Which costs less for the profit it is expected to make?

    Both cost the same for the profit they are expected to make: 17.6× their forward earnings.

  • ABBV

    Which pays more in dividends?

    AbbVie pays more back in dividends for what a share costs: 2.42% a year, against 2.41%.

  • Which do analysts rate higher?

    Analysts rate both the same: Buy.

  • ABBV

    Which is in the stronger price trend?

    AbbVie's price is in the stronger trend: 15.5% above its 200-day average, against 0.0% above.

What each company does

ABBVAbbVie

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

Reports results on 3 February 2027

ABTAbbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide.

Reports results on 28 January 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every US healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.